BridgeMD
New treatment option for Postoperative Pain
Official title Comparison of Erector Spinae Plane Block (ESPB) With the Combination of Superficial Parasternal Intercostal Plane Block (SPIPB) and Serratus Anterior Plane Block (SAPB) in the Management of Postoperative Sternotomy Pain in Patients Undergoing Cardiac Surgery Via Sternotomy
ClinicalTrials.gov ID: NCT07472296
What this study is testing
- What it's testing
- This study aims to compare the effectiveness of two regional anesthesia techniques in managing pain for participants undergoing cardiac surgery via sternotomy. The investigators will evaluate whether the Erector Spinae Plane Block (ESPB) or a combination of the Superficial Parasternal Intercostal Plane Block (SPIPB) and Serratus Anterior Plane Block (SAPB) provides better pain control and recovery outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Patients aged between 18 and 80 years.
- Patients classified as American Society of Anesthesiologists (ASA) physical status I, II, or III.
- Patients scheduled for elective cardiac surgery via median sternotomy.
- Patients who have provided written informed consent.
You likely can't join if
- Pregnancy or suspected pregnancy.
- Body Mass Index (BMI) \> 35 kg/m².
- Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine).
- Suspected coagulopathy or bleeding disorders.
- Infection at the site of the regional block injection.
- Severe hepatic or renal failure.
See the full eligibility criteria
- Patients aged between 18 and 80 years.
- Patients classified as American Society of Anesthesiologists (ASA) physical status I, II, or III.
- Patients scheduled for elective cardiac surgery via median sternotomy.
- Patients who have provided written informed consent.
- Pregnancy or suspected pregnancy.
- Body Mass Index (BMI) \> 35 kg/m².
- Known allergy or hypersensitivity to local anesthetics (e.g., bupivacaine).
- Suspected coagulopathy or bleeding disorders.
- Infection at the site of the regional block injection.
- Severe hepatic or renal failure.
- Severe neurological or psychiatric disorders.
- Emergency surgical procedures.
- Re-operation cases (Redo-surgery)
The study team makes the final eligibility decision.
Where it's taking place
- Bursa, Nilüfer, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bursa, Nilüfer, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.